Change of the Pattern of the Demographic Characteristics of the Patients with Endocarditis: Clinical Case of Infectious Endocarditis in Man with Injectible Drug Dependence, Complicated with Pneumonia and Peripheral Necroses of Feet, Arms, Nose (Own Clinical Observations and Experience of Education in State and English Language)
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Infectious endocarditis is multisystem disease, which is the result of the infection (usually bacterial) of endocardial heart surface. Despite of the latest medical achievements in diagnostics and treatment, infectious endocarditis is still a disease with high mortality rate and severe complications. During last decades in developed countries there are obvious changes of demographic characteristics of the patients with infectious endocarditis, namely increasing of aged patients with degenerative valvular diseases, of patients with anamnesis of invasive manipulations and procedures. Beside with well known risk factors (artificial valves and implanted heart devices), there are increasing roles of injectible drug-dependence, human immunodeficiency virus and wide contact with health protection system as predisposing factors for infectious endocarditis. The article contains literature data of the main populational risk groups of infectious endocarditis.
Clinical case of severe (fatal) infectious endocarditis in patient with injectible drug dependence is submitted. Special features of the case are peripheral dry necroses of feet, arms, nose, which are very close to the description of symmetrical peripheral gangrene. This rare disorder was first described by Hutchinson in 1891 in 37-year old man, who had gangrene of fingers, hands and ears after shock. Symmetrical peripheral gangrene can be induced by different infection and non-inflection causes. The majority of these cases are connected to the treatment of cardiogenic shock with disseminated intravascular coagulation.
Submitted description of the case of symmetrical peripheral gangrene in patient with infectious endocarditis will be useful for different medical care specialists as a reminder of the necessity of constant monitoring of the skin color of the distal parts of the limbs in severe sick patients.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Contrepois A. Towards a history of infective endocarditis. Med. Hist. 1996;40:25–54.
Osler W. The Gulstonian Lectures on Malignant Endocarditis. BMJ. 1885;1:577–9.
Kaye D. Changing pattern of infective endocarditis. Am. J. Med. 1985;78:157–62.
Bin Abdulhak AA. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Glob. Heart. 2014;9:131–43.
Thayer W. Studies on bacterial (infective) endocarditis. Johns Hopkins Hosp. Rep. 1926;22:1.
Fowler VG. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012–21.
Murdoch DR. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International collaboration on endocarditis-prospective cohort study. Arch. Intern. Med. 2009;169:463–73.
Rabinovich S, Evans J, Smith IM et al. A long-term view of bacterial endocarditis. 337 cases 1924 to 1963. Ann. Intern. Med. 1965;63:185–98.
Watt G. Prospective comparison of infective endocarditis in Khon Kaen, Thailand and Rennes, France. Am. J. Trop. Med. Hyg. 2015;92:871–4.
Greenspon AJ. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J. Am. Coll. Cardiol. 2011;58:1001-6.
Thiene G, Basso C. Pathology and pathogenesis of infective endocarditis in native heart valves. Cardiovasc. Pathol. 2006;15:256–63.
Movahed MR, Saito Y, Ahmadi-Kashani M, Ebrahimi R. Mitral annulus calcification is associated with valvular and cardiac structural abnormalities. Cardiovasc. Ultrasound. 2007;5:14.
Benito N. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann. Intern. Med. 2009;150:586–94.
Şimşek-Yavuz1 S, Rüçhan AA, Aydoğdu S et al. Consensus report on diagnosis, treatment and prevention of infective endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Societyof Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group. Turk. J. Th. Cardiovasc. Surg. 2020;28:2-42.
Lamas CC, Fournier PE, Zappa M et al. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases. Infect. 2016;44:459-466.
Morris AJ, Drinkovic D, Pottumarthy S et al. Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clin. Infect. Dis. 2003;36:697-704.
Raoult D, Casalta JP, Richet H et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J. Clin. Microbiol. 2005;43:5238-42.
Topan A, Carstina D, Slavcovici A et al. Assesment of the Duke criteria for the diagnosis of infective endocarditis after twenty-years. An analysis of 241 cases. Clujul Med. 2015;88:321-6.
Liesman RM, Pritt BS, Maleszewski JJ, Patela R. Laboratory diagnosis of infective endocarditis. J. Clin. Microbiol. 2017;55:2599-608.
Gould FK, Denning DW, Elliott TS et al. Working Party of the British Society for Antimicrobial Chemotherapy. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. Antimicrob. Chemother. 2012;67:269-89.
Piletskyi AM, Snigir NV, Rudichenko VM, Krivetz VO, Maslyi MG. Difficult differential diagnosis of hemorrhagic vasculitis in the practice of general practitioner-family physician: own clinical observations and literature data. Family Medicine. 2019;2:49-53.
Rudichenko VM, Lubchenko AS, Reizin DV, Barasyi SM, Snigir NV, Simonenko SV. Chilaiditi syndrome: rare and demonstrative (after materials of own clinical observations). Art of Medicine. 2016;9-10:44-8.
Dong J, Zhang L, Rao G et al. Complicating symmetric peripheral gangrene after dopamine therapy to patients with septic shock. J. Forensic Sci. 2015;60:1644-6.
Sharma BD, Kabra SR, Gupta B. Symmetrical peripheral gangrene. Trop. Doct. 2004;34:2-4.
Shenoy R, Agarwal N, Goneppanavar U et al. Symmetrical peripheral gangrene – a case report and brief review. Indian J. Surg. 2013;75:163-5.
Hayes MA, Yau EH, Hinds CJ et al. Symmetrical peripheral gangrene: association with noradrenaline administration. Intens. Care Med. 1992;18:433-6.
Akamatsu S, Kojima A, Tanaka A et al. Symmetric peripheral gangrene. Anesthesiol. 2013;118:1455.
Davis MD, Dy KM, Nelson S. Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic. J. Am. Acad. Dermatol. 2007;57:944-56.
Silbart S, Oppenheim W Purpura fulminans. Medical, surgical, and rehabilitative considerations. Clin. Orthop. Relat. Res. 1985;193:206-13.
Johansen K, Hansen ST. Gangrene s. purpura fulminans complicating pneumococcal sepsis. Am. J. Surg. 2017;165:642-5.
Molos MA, Hall JC. Symmetrical peripheral gangrene and disseminated intravascular coagulation. Arch. Dermatol. 1985;121:1057-61.
